EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Artesunate repurposing for cytomegalovirus management: a systematic review of efficacy, mechanisms, and perspectives

Haohao Zhang, Fanchao Zhou, Jianping Song, Changsheng Deng, Xiao He, Suiqin Ni

Frontiers in Cellular and Infection Microbiology · 07.05.2026 · 16

DOI: 10.3389/fcimb.2026.1815679 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 07.05.2026. Verfasst von Haohao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Artesunate, Antiviral Agents, Cytomegalovirus Infections, Cytomegalovirus. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytomegalovirus (CMV) is a prevalent opportunistic pathogen associated with significant morbidity and mortality in immunocompromised individuals, particularly transplant recipients and neonates. Current antiviral therapies are often constrained by substantial toxicity and the emergence of drug resistance. Artesunate (ART), a proven antimalarial agent with established safety profiles, has been explored for potential repurposing against CMV infection, though its anti-CMV pharmacodynamics remain incompletely elucidated.

Methods

This systematic review synthesized evidence from 46 studies published through December 2025, covering in vitro , in vivo , and clinical studies, to evaluate the efficacy, mechanisms of action, and translational challenges of ART-based anti-CMV strategies.

Results

ART exhibits potent anti-CMV activity in vitro , with no reported cross-resistance to conventional antiviral agents. Structure–activity relationship analysis indicates that the endoperoxide bridge and hemisuccinate side chain may contribute to its antiviral effects. While optimized ART derivatives show improved potency, they remain in the preclinical research stage. Clinical evidence for ART is limited, primarily derived from small-scale and combination therapy studies, with inconsistent outcomes typically marked by an initial reduction in viral load rather than sustained complete clearance. Mechanistically, ART may exert anti-CMV effects through multiple host-regulated pathways, including NF-κB inhibition, G0/G1 cell cycle arrest, and modulation of mitochondrial dynamics.

Conclusions

The short plasma half-life of ART may represent a pharmacokinetic limitation to its clinical application. Further research, including formulation optimization, targeted pharmacokinetic/pharmacodynamic studies, and well-controlled clinical trials, is warranted to evaluate the potential role of ART in CMV management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtesunateAntiviral AgentsCytomegalovirus InfectionsCytomegalovirusDrug RepositioningHumansAnimalsViral Load

Stichwörter der Autor:innen

CMV infectionantiviralartemisininartesunatecytomegalovirushcmv

Substanzen

ArtesunateAntiviral Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, H., Zhou, F., Song, J., Deng, C., He, X., & Ni, S. (2026). Artesunate repurposing for cytomegalovirus management: a systematic review of efficacy, mechanisms, and perspectives. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1815679

Vancouver

Zhang H, Zhou F, Song J, Deng C, He X, Ni S. Artesunate repurposing for cytomegalovirus management: a systematic review of efficacy, mechanisms, and perspectives. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1815679

BibTeX
@article{Zhang2026,
  author = {Zhang, Haohao and Zhou, Fanchao and Song, Jianping and Deng, Changsheng and He, Xiao and Ni, Suiqin},
  title = {Artesunate repurposing for cytomegalovirus management: a systematic review of efficacy, mechanisms, and perspectives},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1815679}
}
Kostenlos starten →